• Feb 23, 2026 Usfda Post Approval Changes ter innovation while ensuring product quality and patient safety are not compromised. Furthermore, the FDA’s recent guidance on the Chemistry, Manufacturing, and Controls (CMC) post approval change management protocols (PACMP) reflects a move toward more flexible change By Akeem Rippin
